Clinical trial
Pulse Versus Continuous Cyclophosphamide for Induction of Remission in…
NCT00430105 · Cambridge University Hospitals NHS Foundation Trust, Other · Completed
Key facts
| NCT number | NCT00430105 |
|---|---|
| Title | Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides |
| Official title | Randomized Trial of Intravenous Pulse Versus Oral Continuous Cyclophosphamide for Induction of Remission in Systemic ANCA-Associated Vasculitides |
| Lead sponsor | Cambridge University Hospitals NHS Foundation Trust, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | ANCA Associated Systemic Vasculitis, Wegener's Granulomatosis, Microscopic Polyangiitis |
| Intervention type | Drug |
| Interventions | cyclophosphamide |
| Enrollment | 160 |
| Start date | Feb 1, 1998 |
| Completion | Apr 1, 2004 |
| First posted | Feb 1, 2007 |
| Last update posted | Feb 1, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: